>
>
>
Quraxia’s oral dosage development combines technical depth with innovation, addressing the complexities of tablet, capsule, and other oral formulations. The expertise extends across all development phases, from pre-formulation to scalable manufacturing and technology transfer.
Key strengths include:
Advanced process development and optimization for challenging compounds and excipient selection.
Implementation of QbD principles and analytical methods to maintain consistency, purity, and safety.
Regulatory expertise to ensure proper documentation, validation, and compliance.
Strategically designed stability studies and packaging recommendations to maintain product quality.
Special capabilities cover bi-layer tablets, multiparticulate systems (pellets or mini-tablets in capsules), fixed-dose combinations, high-potency and modified-release products, oral solutions, suspensions, and powder sachets. Each formulation is designed with both therapeutic effectiveness and patient convenience in mind.
